Archives

  • 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2020-03
  • 2020-07
  • 2020-08
  • br Other factors to consider

    2020-08-28


    Other factors to consider regarding adolescent vaccine ac-ceptance that may merit future study include the potential impacts of social media and peer pressure. Depending on the source and content of social media postings or the focus of direct or indirect peer pressure, substantial shifts in either vaccine acceptance or refusal could ensure. Such effects might impact Atezolizumab rates among small groups of friends, but it is also feasible that larger scale influences could develop across those attending a particular school or to a larger number of teens living in the same community.
    A strong vaccine recommendation from a provider who is confident and knowledgeable about the HPV vaccine in ad-dition to messages regarding HPV vaccine as cancer preven-tion motivates HPV vaccinations.38-40 Our multicomponent intervention was associated with small to moderate increases in HPV vaccination rates among the recruited practices. It is likely that additional systematic changes will be needed to op-timize vaccine uptake in this population. Future larger studies are needed to measure the effect of a cancer prevention plat-form on adolescent HPV vaccine completion rates. ■
    We thank the New York State Immunization Information Systems team for their assistance in obtaining statewide and countywide vaccination rates.
    150 Suryadevara et al
    February 2019 ORIGINAL ARTICLES
    Reprint requests: Manika Suryadevara, MD, Department of Pediatrics, SUNY Upstate Medical University, 750 East Adams St, Syracuse, NY 13210. E-mail: [email protected]
    References
    1. Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014;63:1-30.
    2. Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fedua B, et al. National, regional, state, and selected local area vaccination cov-erage among adolescents aged 13-17 years—United States, 2016. MMWR Morb Mortal Wkly Rep 2017;66:874-82.
    3. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Bar-riers to human papillomavirus vaccination among US adolescents. A sys-tematic review of the literature. JAMA Pediatr 2014;168:76-82.
    4. Bonville CA, Domachowske JB, Cibula DA, Suryadevara M. Immuniza-tion attitudes and practices among family medicine providers. Hum Vaccin Immunother 2017;13:2646-53.
    5. Bynum SA, Staras SAS, Malo TL, Giuliano AR, Shenkman E, Vadaparampil ST. Factors associated with Medicaid providers’ recommendation for the HPV vaccine to low-income adolescent girls. J Adolesc Health 2014;54:190-6.
    6. Griffioen AM, Glynn S, Mullins TK, Zimet GD, Rosenthal SL, Fortenverry JD, et al. Perspectives on decision making about human papillomavirus vaccination among 11- to 12- year old girls and their mothers. Clin Pediatr (Phila) 2012;51:560-8.
    7. Jeudin P, Liveright E, del Carmen MG, Perkins RB. Race, ethnicity, and income factors impacting human papillomavirus vaccination rates. Clin Ther 2014;36:24-37.
    8. Brawner BM, Baker JL, Voytek CD, Leader A, Cashman RR, Silverman R, et al. The development of a culturally relevant theoretically driven HPV prevention intervention for urban adolescent females and their parents/ guardians. Health Promot Pract 2013;14:624-36.
    9. Kennedy S, Osgood R, Rosenbloom L, Feinglass J, Simon M. Knowledge of human papillomavirus among publicly and privately insured women. J Midwifery Women’s Health 2011;56:481-7.
    10. Gowda C, Schaffer SE, Dombrkowski KJ, Dempsey AF. Understanding attitudes toward adolescent vaccination and the decision-making dynamic among adolescents, parents, and providers. BMC Public Health 2012;12:509.
    11. Gargano LM, Herbert NL, Painter JE, Sales JM, Morfaw C, Rask K, et al. Impact of a physician recommendation and parental immunization at-titudes on receipt or intention to receive adolescent vaccines. Hum Vaccin Immunother 2013;9:2627-33.
    12. Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 2010;126:425-33.
    13. Shay LA, Street RL, Baldwin AS, Marks EG, Lee SC, Higashi RT, et al. Char-acterizing safety-net providers’ HPV vaccine recommendations to un-decided parents: a pilot study. Patient Educ Couns 2016;99:1452-60.
    14. Berkowitz Z, Malone M, Rodriguez J, Saraiya M. Providers’ beliefs about the effectiveness of HPV vaccine in preventing cancer and their recom-mended age groups for vaccination: findings from a provider survey, 2012. Prev Med 2015;81:405-11.
    16. Centers for Disease Control and Prevention. Human papillomavirus. www.cdc.gov/vaccines/parents/diseases/teen/hpv-indepth-color.pdf. Ac-cessed September 25, 2018.
    17. Immunization Action Coalition. Every week hundreds of people get hepatitis B. www.immunize.org/catg.d/p4112.pdf. Accessed September 25, 2018.